UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended July 31, 2020

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________to ______________

 

Commission File Number 000-56135

 

HEMP TECHNOLOGY INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Wyoming		98-0490694
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification Number)

 

2901 Gardena Avenue Signal Hill, California		90755
(Address of Principal Executive Offices)		(Zip Code)

 

(437) 230-7399

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common Shares, Par Value $0.00001		HPTY		OTC-Pink Sheets

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ]	Accelerated filer [  ]
Non-accelerated filer [  ]	Smaller reporting company [X]
	Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

As of July 31, 2020 44,029,197,258 of the registrant’s $0.00001 par value common shares were outstanding.

 

 

 

Explanatory Note

 

This Amendment No. 1 on Form 10-Q/A amends Hemp Technology’s (“the Company’) Quarterly Report on Form 10-Q for the quarter ended July 31, 2020, which the Company previously filed with the U. S. Securities and Exchange Commission on September 21, 2020. The Company is filing this Amendment to state that it inadvertently filed the Original Form 10-Q without the review nor consent of its auditors. The Company’s auditors have not reviewed any of the information presented in the Original Form 10-Q. The auditors are not responsible for this oversight. Therefore, the information presented cannot be relied upon. The Company plans to amend this Form 10-Q/A, after the auditors have an opportunity to review and consent to the filing.

 

Except as described above, this Form 10-Q/A does not modify or update disclosure in, or exhibits to, the original Form 10-Q. Information not affected by this Form 10-Q/A remains unchanged and reflects the disclosures made at the time the original Form 10-Q was filed. For ease of reference, the entire original Form 10-Q, including all other exhibits filed therewith, is included with this Amendment.

 

 

HEMP TECHNOLOGY INC.

FORM 10-Q FOR THE THREE MONTHS ENDED July 31, 2020

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION		1
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets (Unaudited)	1
	Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)	2
	Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows (Unaudited)	4
	Notes to the Condensed Consolidated Financial Statements (Unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	8
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	12
Item 4.	Controls and Procedures	12
PART II – OTHER INFORMATION		13
Item 1.	Legal Proceedings	13
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	13
Item 6.	Exhibits	14
SIGNATURES		15

 

 

PART I - FINANCIAL INFORMATION

 

Hemp Technology Inc.

Unaudited Interim Condensed Consolidated Balance Sheets

As of July 31, 2020, and April 30, 2020

(Amounts Expressed in United States Dollars, Except for Share Amounts)

 

		July 31,				April 30,
		2020				2020
		(Not Reviewed)				(Audited)
ASSETS
Current Assets:
Cash and Cash Equivalents		$	1,024				970
Accounts Receivable			982,355
Inventories			1,117,163
Total Current Assets			2,100542				970
Property and Equipment, Net			74,214
Intangible Assets, Net			136,473
TOTAL ASSETS		$	2,311,229				970
LIABILITIES AND SHAREHOLDERS’ EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable		$	27,170				42,500
Due to related parties							172,390
Total Current Liabilities			27,170				214,890
TOTAL LIABILITIES			27,170				214,890
SHARE HOLDERS’ EQUITY
Share Capital			440,292				211,763
Common stock, $0.00001 par value, 50,000,000,000 shares authorized; 44,029,197,258 shares issued and outstanding as at July 31, 2020 and 21,176,289,678 as at April 30, 2020 respectively
Additional paid in capital			9,061,944				7,005,181
Accumulated Deficit			(7,218,176	)			(7,430,865	)
TOTAL SHAREHOLDERS’ EQUITY			2,284,060				(213,920	)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	2,311,229				970

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

 

 

Hemp Technology Inc.

Unaudited Interim Condensed Consolidated Statements of Operations

Three Months Ended July 31, 2020 and 2019

(Amounts Expressed in United States Dollars, Except for Share Amounts)

 

		Three Months Ended July 31,
		2020 (Not Reviewed)				2019 (Not Reviewed)
Revenues, net of discounts		$	982,365
Cost of Goods Sold, net			(718,395	)
Gross Profit			263,970
Expenses:
Selling, General, and Administrative			51,281				105,054
Total Expenses			51,281				105,054
Income (Loss) From Operations			212,789				(105,054	)
Net Loss per share - basic and diluted		$	0.00				(0.00	)
Weighted average number of shares outstanding - basic and diluted			29,926,271,714				18,749,106,433

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

 

 

Hemp Technology Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

(Amounts Expressed in United States Dollars, Except for Share Amounts)

 

		Common Stock								Shares				Additional				Accumulated				Total Stockholders’
		Number of Shares				Par value				To be Issued				Paid in Capital				Earnings (Deficit)				Equity (Deficit)
Balance, April 30, 2019			18,546,628,778			$	185,466			$	191,551			$	6,768,512			$	(7,076,990	)		$	68,539
Net Income (Loss)																			(105,054	)			(105,054	)
Balance, July 31, 2019			18,546,628,778			$	185,466			$	191,551			$	6,768,512			$	(7,182,044	)		$	(36,515	)
Balance, April 30, 2020			21,176,289,678			$	211,763			$				$	7,005,181			$	(7,430,865	)		$	(213,920	)
Shares issued for Bulk Asset Purchase			22,852,907,580				228,529								2,056,762								2,285,291
Net Income (Loss)																			212,689				212,689
Balance, July 31, 2020			44,029,197,258			$	440,292			$				$	9,061,944			$	(7,218,176	)		$	2,284,060

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

 

 

Hemp Technology Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Three Months Ended July 31, 2020 and 2019

(Amounts Expressed in United States Dollars)

 

		Three Months Ended July 31,
		2020 (Not Reviewed)				2019 (Not Reviewed)
Operating activities
Net Income (Loss)		$	212,689				(105,054	)
Changes in operating assets and liabilities:
Accounts receivable			(982,355	)
Inventory			(1,117,163	)
Property, Equipment and Intangible assets			(210,687	)
Accounts payable and accrued liabilities			(15,331	)			35,800
Shares to be issued - services rendered							45,000
Net cash used in operating activities			(2,112,847	)			(24,254	)
Financing activities
Due to related party			(172,390	)			(7,727	)
Shares Issued for Purchase of Bulk Assets			2,285,291
Net cash provided by financing activities			2,112,901				(7,727	)
Net changes in cash			54				(31,981	)
Cash at beginning of period			970				85,981
Cash at end of the year		$	1,024				54,000

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

 

 

Hemp Technology Inc.

Notes to the Condensed Consolidated Financial Statements

Presented in U.S. Dollars

 

Note 1 - Company overview

 

Hemp Technology Inc. of Wyoming and its subsidiaries, Hemp Technology Inc. of Kentucky, Hemp Biotech Inc. of Kentucky, and Sol Terra SAS of Colombia (collectively the “Company”) is publicly listed on the OTC under the symbol “HPTY.” The Company’s registered office is in Cheyenne, Wyoming and its principal executive office is located in Signal Hill, CA. The Company is a start-up in the production and distribution of innovative hemp-based, products. The Company’s planned primary products will be created from high quality strains of hemp. Hemp extracts are produced from industrial hemp, which is defined as Cannabis with less than 0.3% tetrahydrocannabinol (THC). THC causes psychoactive effects when consumed and is typically associated with marijuana (i.e. cannabis with high-THC content). The Company does not produce or sell medicinal or recreational marijuana or products derived from high-THC Cannabis/marijuana plants and is focused on industrial hemp usage related to fiber, building materials, seed derived oils and proteins.

 

Note 2 - Going concern

 

These condensed consolidated financial statements are prepared on a going concern basis. The Company has incurred continuing losses from its operations and as of July 31, 2020, the Company had an accumulated deficit of $7,218,176 resulting primarily from its previous biofuels business. The Company had a Net loss of $ 353,875 during its most recent year ended April 30, 2020 and a net income $212,689 in the three months ended July 31, 2020. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Note 3 - Basis of preparation

 

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10–Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10 for the fiscal year ended April 30, 2020.

 

Basis of consolidation – The consolidated financial statements include the accounts of Hemp Technology Inc. and its subsidiaries, as of July 31, 2020 and 2019. The Company has six wholly owned subsidiaries: Hemp Technology Inc. of Kentucky, Hemp Biotech Inc. of Kentucky, Sol Terra SAS of Colombia 4033000, 4033001 and 4033002 of Wyoming. Inter-company balances and transactions are eliminated in preparing the consolidated financial statements. The accounting policies of the subsidiaries are consistent with Hemp Technology Inc.

 

Use of estimates - The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses. We believe that the accounting estimates employed are appropriate and that the resulting balances are reasonable; however, due to the inherent uncertainty in making estimates, actual results could differ from the original estimates, resulting in changes to these balances in future periods.

 

 

Net Loss per share

 

We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, and diluted earnings per share is computed by including common stock equivalents outstanding for the period in the denominator. For the three months period ended July 31, 2020 and 2019, any equivalents would have been anti-dilutive as we had a loss for the period then ended.

 

Foreign Currency Translation

 

The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent is the U.S. dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in accumulated other comprehensive loss in the condensed consolidated balance sheets.

 

Fair Values of Financial Instruments

 

The carrying amounts of cash, accounts payable, and accrued liabilities approximate their fair value due to the short-term nature of these instruments. The Company’s operations and financing activities are conducted primarily in United States dollars and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash but mitigates this risk by keeping these deposits at major financial institutions.

 

ASC 820 “Fair Value Measurements and Disclosures” provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).

 

Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability.

 

Income taxes

 

The Company utilizes the liability approach for accounting and reporting for income taxes. The provision for income taxes is based upon income or loss after adjustment for those permanent items that are not considered in the determination of taxable income. Deferred income taxes represent the tax effects of differences between the financial reporting and tax basis of the Company’s assets and liabilities at the enacted tax rates in effect for the years in which the differences are expected to reverse.

 

The Company evaluates the recoverability of deferred tax assets and establishes a valuation allowance when it is more likely than not that some portion or all the deferred tax assets will not be realized. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In management’s opinion, adequate provisions for income taxes have been made. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

 

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards.

 

 

The Company’s policy for recording interest and penalties associated with tax audits is to record such items as a component of general and administrative expense. The Company has identified its federal tax return and its state tax return in Kentucky as its “major” tax jurisdictions, and all prior year returns remain subject to examination. The Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017. The Tax Act reduced the U.S. federal corporate tax rate from 35% to 21%. As December 31, 2017, the Company had made a reasonable estimate of the effects of the Tax Act. This estimate incorporates assumptions made based upon the Company’s current interpretation of the Tax Act and may change as the Company may receive additional clarification and implementation guidance and as the interpretation of the Tax Act evolves. In accordance with SEC Staff Accounting Bulletin No. 118, the Company has finalized the accounting for the effects of the Tax Act during 2020. Future adjustments made to the provisional effects will be reported as a component of income tax expense in the reporting period in which any such adjustments are determined.

 

Stock based compensation

 

The Company follows ASC 718, Compensation - Stock Compensation, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the more readily measurable of the fair value of the stock and the fair value of the service. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock- based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and management, this is typically considered to be the vesting period of the award. For consultants, the fair value of the award is recorded over the term of the service period, and unvested amounts are revalued at each reporting period over the service period. The Company estimates the expected forfeitures and updates the valuation accordingly.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

 

Note 4 - Due to related parties and management compensation

 

All Interco transaction have been eliminated.

 

Note 5 - Common stock and Shares to be issued

 

The Company’s authorized share capital consists of 50 billion of shares of common stock and 10 billion of preferred stock. There are no preferred shares issued, and 44,029,197,258 common shares issued at July 31, 2020.

 

During the three months ended July 31, 2020:

 

	●	the Company issued 100,000,000 shares of common stock to the owners of the assets as part of the Bulk Asset Purchase Agreement dated May 26, 2020 valued at $100,000 USD.
	●	the Company issued 21,852,907,580 shares of common stock to the stockholders of the assets as part of the Bulk Asset/Share Exchange Agreement dated May 7, 2020 valued at $2,185,291 USD.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

As used in this registration statement, the terms “we”, “us” and “our” mean Hemp Technology Inc. and its subsidiaries, Hemp Technology Inc., Hemp Biotech Inc., Sol Terra, 4033000, 4033001 and 4033001 unless otherwise specified. In this registration statement, the terms “dollar”, “US$” or “$” refer to United States dollars and the term CDN$ refers to Canadian dollars.

 

Forward-Looking Statements

 

This registration statement contains forward-looking statements. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “intend”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, including the risks in the section entitled “Risk Factors”, uncertainties and other factors, which may cause our company’s or our industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity or performance. Except as required by applicable law, including the securities laws of the United States and Canada, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Corporate History

 

Our company was originally incorporated in July 2005 in Nevada under the name “Loma Verde Inc.” Our company was initially formed for the purpose of acquiring and developing mineral properties and was therefore considered to be in the pre-exploration stage. Mineral claims with unknown reserves were acquired, but we did not establish the existence of commercially mineable ore deposits and we decided to abandon our mineral claims and to pursue other business opportunities, one of which was the alternative energy business.

 

In March 2007, we engaged in a merger with our wholly owned subsidiary, “Clean Power Concepts Inc.”, for the purpose of changing our name.

 

In April 2010, we changed our business focus to the operation of the business conducted by our subsidiary “General Bio Energy Inc.”, which was focused on the environmentally friendly green energy industry. General Bio Energy Inc. was incorporated in the Province of Saskatchewan in February 2006 under the name “Canadian Green Fuels Inc.” and changed its name to “General Bio Energy Inc.” in September 2008. General Bio Energy Inc. commenced its pre-production stage in May 2006 and began selling products in July 2008. From 2008 to 2011, we were engaged in the development of a bioenergy business focused on agricultural processing and the environmentally friendly green energy industry. We produced a range of products manufactured by crushing oilseeds and refining the by-products. Our subsidiary, General Bio Energy Inc., operated a fully integrated commercial oilseed crushing, bio-diesel refinery, which used its proprietary processes to produce two main co-products, oil and meal, each of which were further processed and then sold. The oil products produced from this process could be divided into three subcategories: (i) vegetable oil for human and animal consumption; (ii) biofuel and biofuel additives; and (iii) environmental lubricants and conditioners, penetrating sprays, dust suppressants, cutting oils and other “ECO-lubricants”. We also added a new group of oil products to our product mix: natural consumer health products. The meal and protein related products were used for agricultural and aquaculture feedstock. We considered our facility to be a “green” manufacturing facility because it had minimal effluents, using methods which are emissions friendly. Our production facility and head office were located in Regina, Saskatchewan.

 

 

From 2012 to 2019, we focused on clearing our debts from prior biofuels operations by issuing shares in exchange for the settlement of these liabilities, and on seeking a different venture for our shareholders. In 2013, our company changed its corporate jurisdiction to the State of Wyoming.

 

Our Current Business

 

On January 18, 2020, we changed our name to “Hemp Technology Inc.” and announced a new business plan in the emerging hemp related products business. We hired new management to carry out these plans and raised $0.3 million seed capital between March and September 2020 to commence the process.

 

The Company operates and intends to further obtain a diversified portfolio of subsidiary companies. Focusing on a variety of assets, products, and ancillary offerings in the hemp and related industries, the Company’s fluid business model is positioned to capitalize on, and adapt to, changing market conditions. Management of the Company continues to seek opportunities and strategic acquisitions that support its business model. Hemp Technology Inc., operates and intends to further augment their diversified portfolio of subsidiary companies. Focusing on a variety of assets, products, and ancillary offerings in the hemp and related industries, HPTY’s fluid business model is positioned to capitalize on, and quickly adapt to, changing market conditions. The Company is continually seeking opportunities and strategic acquisitions that support its business model and maintain alignment with the dynamic industry environment. The Company consists of subsidiaries which hold two hemp processing licenses in the state of Kentucky, Cannary Distribution in the Los Angeles metropolitan area, Verified Vapes, hardware manufacturer, and Pettanicals a high-quality nutritional pet supplement performance products brand. The Company currently has operations in the U.S. and Canada.

 

On May 2, 2020, Hemp Technology, a Wyoming corporation (the “Registrant” or “the Company”) and its wholly owned subsidiary 4033002, a newly formed Wyoming Corporation entered into an Asset/Share Exchange Agreement and corresponding Bulk Asset Sale Agreement with Cannary Packaging, Inc., “Cannary”), a private British Columbia company. Under the terms of the Asset/Share Exchange Agreement, Cannary agreed to exchange its non-operating assets to 4033002, the Registrant’s subsidiary. The non-operating assets were valued at approximately $2,200,000 and were exchanged for 21,852,907,580 of the Registrant’s unregistered restricted common shares (the “Issued Shares”) of newly issued common stock to existing shareholders of Cannary based on their pro-rata ownership in Cannary.

 

The purpose of acquiring these Non-Operating Assets is twofold: 1) 4033002 becomes the operating asset acquisition subsidiary for the Registrant; and 2) the acquisition of these Non-Operating Assets helps qualify Registrant for a NASDAQ listing.

 

On May 20, 2020, Hemp Technology, a Wyoming corporation (the “Registrant” or “the Company”) and its wholly owned subsidiary 4033001, a newly formed Wyoming Corporation entered into a Bulk Asset Sale Purchase Agreement with Vanessa Miskuski and Chad Costa. Under the terms of the Bulk Asset Sales Purchase Agreement Vanessa and Chad Costa agreed to sell to 4033001, the Registrant’s subsidiary, bulk assets, valued at $100,000, in exchanged for 1,000,000,000 unregistered restricted common shares of the Registrant. These bulk assets were formerly owned by Pettanicals Pet Treats, Inc., a private Canadian company, which has been dissolved in accordance with section 314(1) of the British Columbia Business Corporations Act.

 

Their assets are now the property of the former two owners. Management believes that by purchasing these assets, it may be able to revive the pet vitamin business, which is now defunct. There is no assurance or guarantees that management will be successful or able to revive this former business.

 

 

Results of Operations

 

Revenue

 

Comprised of sales made to other distributors.

 

Operating Expenses

 

We incurred operating expenses of $51,281 during the three months ended July 31, 2020. These expenses were primarily the result of engaging key staff to develop our business plan and fulfilling public company reporting obligations. Generally, the operation expenses were much lower due to the reduction of business and staff being laid off due to the pandemic as a result of the Corona Virus (Covid-19).

 

During the comparable periods in 2019, we were significantly higher.

 

Net Income from Operations

 

We incurred a Net operating income of $211,228 before other income, provision for income taxes net loss from operations during the three-month period ended July 31, 2020 and a net loss of $105,054 in the comparable period in 2019.

 

		For the Three Months Ended July 31,
		2020 (Not Reviewed)				2019 (Not Reviewed)
Revenue		$	982,365			$	-
Cost of Goods			718,395
Operating Expenses			51,281				105,054
Net Income (Loss)			212,689				(105,054	)
Net loss per share - basic and diluted		$	(0.00	)		$	(0.00	)

 

Liquidity and Capital Resources

 

		For the Three Months Ended July 31,
		2020 (Not Reviewed)				2019 (Not Reviewed)
Cash flow from operating activities		$	(2,117,847	)		$	(24,254	)
Cash flow from financing activities			2,112,901				(7,727	)
Net cash flow			54				(31,981	)

 

Net cash used in operating activities

 

For the three-month period ended July 31, 2020 the Company had net income of $212,689. Shares were issued to purchase the bulk assets and intangible asset valued at $2,300,000. During the comparable period in 2019, the Company had minimal activity.

 

For the three-month period ended July 31, 2020 the Company had net income of $212,689; $15,553 of decreased current liabilities and $1,327,849 increase in assets $982,355 increase in accounts receivable yielding a cash flow consumed in operating activities of $2,112,817.

 

 

Net cash provided by financing activities

 

During the three-month period ended July 31, 2020 we issued $2,285,591 of common shares in a private placement. Bulk asset/share agreement. During the comparable periods in 2019 the Company had no financing activities.

 

Working capital

 

		As at July 31, 2020 (Not Reviewed)				As at April 30, 2020 (Not Reviewed)
Current Assets		$	2,100,542			$	972
Current Liabilities			27,170				214,890
Working Capital (Deficit)			2,073,372				(213,918	)

 

The Company’s current assets are substantially made up of Accounts receivables and Inventory. Cash balances decreased since April 30, 2020 due to expenditures to advance the business plan, which was partially offset by funds raised by issuing shares during the three-month period.

 

The Company’s current liabilities are made up of accounts payable and accrued liabilities.

 

Going concern

 

The Company has incurred continuing losses from its operations and as of April 30, 2020, the Company had an accumulated deficit of $7,430,865 resulting primarily from its previous biofuels business. The Company had net income of $212,689 during its most recent year ended April 30, 2020 and a loss of $211,229 in the three months ended July 31, 2020.

 

Off Balance Sheet Arrangements

 

As of July 31, 2020, the company had no off balance-sheet arrangements. The Company has not entered into any specialized financial agreements to minimize its investment risk, currency risk or commodity risk.

 

Critical Accounting Estimates and Policies

 

The preparation of these condensed consolidated financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of expenses during the reporting period.

 

Significant assumptions about the future and other sources of estimation uncertainty that management has made at the end of the reporting period, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, include, but are not limited to, the following: fair value of transactions involving shares of common stock, assessment of the useful life and evaluation for impairment of intangible assets, valuation and impairment assessments on mineral properties, deferred contingent consideration, the reclamation liability, valuation of stock-based compensation, valuation of available-for-sale securities and valuation of long-term debt, HST and asset retirement obligations. Other areas requiring estimates include allocations of expenditures, depletion and amortization of mineral rights and properties.

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

NA

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on their evaluation of our disclosure controls and procedures, our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were not effective as of July 31, 2020, to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is (a) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (b) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow for timely decisions regarding required disclosure.

 

Description of Material Weakness

 

Management has concluded that the Company’s disclosure controls and procedures were not effective as of July 31, 2020, due to the lack of segregation of duties.

 

Remediation of Material Weakness

 

Management has developed a plan to put the proper staff in place, which will not be implemented until the Company is funded and begins operations.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during the current fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

In the opinion of management, we are not involved in any claims, legal actions or regulatory proceedings as of July 31, 2020, the ultimate disposition of which would have a material adverse effect on our consolidated financial position, results of operations, or cash flows.

 

Item 1A. Risk Factors

 

For information on risk factors, please refer to “Risk Factors” in the Company’s Form 10 Registration Statement, Section 1A, for the year ended April 30, 2020.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the three-month period ended July 31, 2020 the company issued common stock as follows:

 

	●	100,000,000 shares of common stock to the owners of the assets as part of the Bulk Asset Purchase Agreement dated June 15, 2020
	●	21,852,907,580 shares of common stock to the stockholders of the assets as part of the Bulk Asset/Share Exchange Agreement dated May 7, 2020

 

 

Item 6. Exhibits

 

Exhibit No.		Description
31.1		Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
31.2		Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
32.1		Section 1350 Certifications – Chief Executive Officer
32.2		Section 1350 Certifications – Chief Financial Officer
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	HEMP TECHNOLOGY INC.
Date: September 25, 2020	By:	/s/ Michael D. Shenher
		Michael D. Shenher
		Chief Executive Officer (Principal executive officer)
Date: September 25, 2020	By:	/s/ Walter Schredl
		Walter Schredl
		Chief Financial Officer (Principal financial and accounting officer)